Skip to main content

Karuna Therapeutics, Inc.

KRTXDelisted Mar 18, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001771917

Karuna Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 18, 2024; 328 institutions reported holding it in 13F filings for Q4 2023, worth $12.0B in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Karuna Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Karuna Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Karuna Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Jonas Jeffrey MDirector0Mar 18, 20240
Coughlin Christopher JDirector0Mar 18, 20240
Paul Steven MDirector0IndirectMar 18, 20240
Healy JamesDirector0IndirectMar 18, 20240
Meury WilliamPresident and CEO0Mar 18, 20240
Olson Laurie JDirector0Mar 18, 20240
Pande AtulDirector0Mar 18, 20240
Brannan Stephen K.Chief Medical Officer0Mar 18, 20240
Miller Andrew CraigPresident of R&D0Mar 18, 20240
Wheadon David E.Director0Mar 18, 20240
Kane William P JrChief Commercial Officer0Mar 18, 20240
Torres DeniceDirector0Mar 18, 20240
Brown Jason ParkerChief Financial Officer0Mar 18, 20240
Ignelzi Troy A.Chief Financial Officer30,487Aug 24, 20230
Lykins CharmaineChief Commercial Officer–Nov 30, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 23, 2023 (view filing)Feb 212 daysIgnelzi Troy A.Chief Financial OfficerSSale−6.00K$190.01−$1.14M−16.4%30.5K after
Mar 9, 2023 (view filing)Mar 9Same dayBrannan Stephen K.Chief Medical OfficerSSale−5.00K$189.51−$947.5K−17.5%23.6K after
Apr 5, 2023 (view filing)Apr 32 daysOlson Laurie JDirectorSSale−1.00K$181.02−$181.0K−100.0%0 after10b5-1
Apr 12, 2023 (view filing)Apr 102 daysBrannan Stephen K.Chief Medical OfficerSSale−5.00K$176.88−$884.4K−17.5%23.6K after10b5-1
Apr 20, 2023 (view filing)Apr 18-202 daysMiller Andrew CraigChief Operating OfficerSSale−45.0K$200.15−$9.01M−64.8%24.4K after2 lots10b5-1
May 25, 2023 (view filing)May 232 daysIgnelzi Troy A.Chief Financial OfficerSSale−9.00K$223.41−$2.01M−22.8%30.5K after6 lots10b5-1
Jul 5, 2023 (view filing)Jul 32 daysJonas Jeffrey MDirectorSSale−13.8K$216.42−$2.99M−93.3%990 after4 lots10b5-1
Jul 5, 2023 (view filing)Jul 32 daysOlson Laurie JDirectorSSale−1.00K$215.65−$215.7K−50.3%990 after2 lots10b5-1
Aug 2, 2023 (view filing)Aug 11 dayJonas Jeffrey MDirectorSSale−13.8K$195.81−$2.70M−93.3%990 after5 lots10b5-1
Aug 10, 2023 (view filing)Aug 82 daysBrannan Stephen K.Chief Medical OfficerSSale−5.00K$180.40−$902.0K−16.1%26.1K after3 lots10b5-1
Aug 24, 2023 (view filing)Aug 222 daysIgnelzi Troy A.Chief Financial OfficerSSale−1.50K$175.12−$262.7K−4.7%30.5K after4 lots10b5-1
Sep 5, 2023 (view filing)Sep 14 daysJonas Jeffrey MDirectorSSale−13.8K$187.93−$2.60M−93.3%990 after4 lots10b5-1
Sep 11, 2023 (view filing)Sep 83 daysBrannan Stephen K.Chief Medical OfficerSSale−5.00K$184.04−$920.2K−14.9%28.6K after4 lots10b5-1
Oct 10, 2023 (view filing)Oct 91 dayBrannan Stephen K.Chief Medical OfficerSSale−5.00K$173.24−$866.2K−13.8%31.1K after2 lots10b5-1
Nov 13, 2023 (view filing)Nov 85 daysBrannan Stephen K.Chief Medical OfficerSSale−5.00K$177.85−$889.3K−12.9%33.6K after5 lots10b5-1
Dec 12, 2023 (view filing)Dec 84 daysBrannan Stephen K.Chief Medical OfficerSSale−10.0K$202.37−$2.02M−21.7%36.1K after5 lots10b5-1
Jan 9, 2024 (view filing)Jan 81 dayBrannan Stephen K.Chief Medical OfficerSSale−15.0K$316.81−$4.75M−28.0%38.6K after10b5-1
Feb 12, 2024 (view filing)Feb 84 daysBrannan Stephen K.Chief Medical OfficerSSale−5.00K$316.13−$1.58M−10.8%41.1K after2 lots10b5-1
Mar 11, 2024 (view filing)Mar 83 daysBrannan Stephen K.Chief Medical OfficerSSale−5.00K$318.34−$1.59M−10.5%42.6K after2 lots10b5-1